Cytomos

About:

Cytomos develops and provides integrated, predictive analytics systems for intelligent bioprocessing in biopharma.

Website: https://www.cytomos.com/

Twitter/X: cytomos

Top Investors: Archangels, Scottish Enterprise, British Business Bank, Old College Capital

Description:

Cytomos® develops and provides integrated, predictive analytics systems for intelligent bioprocessing in biopharma and cell therapy domains. Built upon our patented Cytomos® Dielectric Spectroscopy (CDS™) technology, our systems are unbiased, have single-cell resolution and are scalable across all upstream production stages. Leveraging the unmatched data depth per cell provided by CDS™, our proprietary machine learning (ML) algorithms provide insights into your bioprocesses like never before.

Total Funding Amount:

10.7M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Edinburgh, Edinburgh, City of, United Kingdom

Founded Date:

2011-01-01

Contact Email:

info(AT)cytomos.com

Founders:

Keith Muir

Number of Employees:

1-10

Last Funding Date:

2024-11-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai